BWX Technologies, Inc. has entered into a definitive agreement to sell its medical business to Nordic Capital for up to $800 million. BWXT will retain a minority ownership stake in the new entity focusing on radiopharmaceuticals. This transaction enables BWXT to focus resources on its core nuclear markets while providing Nordic Capital the opportunity to scale the medical business. The deal is expected to close by the end of 2026, pending regulatory approvals.
Company Information
Company
Nordic Capital
Location
Stockholm, Stockholm County, Sweden
About
Nordic Capital is a leading global private equity fund that specializes in technology investments. With over 30 years of experience, Nordic Capital has a proven track record of accelerating the growth of innovative technology companies. It has to date made 29 technology investments with an aggregate enterprise value of close to EUR 24 billion.